Correction to : Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?
The authors would like to note that several errors had occurred, especially in Table 2, Tables 5, 6 and 7, Figure 13, and in the legend of Figure 23.
| Errataetall: |
ErratumFor: Rev Endocr Metab Disord. 2018 Dec;19(4):363-395. - PMID 30673921 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Reviews in endocrine & metabolic disorders - 20(2019), 2 vom: 22. Juni, Seite 251-252 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Koch, Christian A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 23.07.2019 published: Print ErratumFor: Rev Endocr Metab Disord. 2018 Dec;19(4):363-395. - PMID 30673921 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s11154-019-09493-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM295259078 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM295259078 | ||
| 003 | DE-627 | ||
| 005 | 20231225083253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11154-019-09493-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0984.xml |
| 035 | |a (DE-627)NLM295259078 | ||
| 035 | |a (NLM)30903391 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Koch, Christian A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties? |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.07.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Rev Endocr Metab Disord. 2018 Dec;19(4):363-395. - PMID 30673921 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The authors would like to note that several errors had occurred, especially in Table 2, Tables 5, 6 and 7, Figure 13, and in the legend of Figure 23 | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Krabbe, Siegfried |e verfasserin |4 aut | |
| 700 | 1 | |a Hehmke, Bernd |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Reviews in endocrine & metabolic disorders |d 2000 |g 20(2019), 2 vom: 22. Juni, Seite 251-252 |w (DE-627)NLM115974520 |x 1573-2606 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2019 |g number:2 |g day:22 |g month:06 |g pages:251-252 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11154-019-09493-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2019 |e 2 |b 22 |c 06 |h 251-252 | ||